ASIA CEO Community

<p>Keith Chong is a seasoned entrepreneur, investor, and advisor with a deep background in life sciences and Medtech. After earning his PhD in Molecular Virology and contributing to two patented technologies, he transitioned into the commercial sector at Merck Life Science, where he advanced from a Southeast Asia Field Application Scientist to Head of Research and later Regional Marketing Manager for key product portfolios in APAC. His leadership played a crucial role in Merck’s response to the COVID-19 pandemic, managing crisis strategies across supply chain, communications, and team training. Sponsored by Merck, he pursued an MBA to refine his strategic and leadership expertise. Following his tenure, Keith co-founded StratifiCare, a Medtech startup, before fully embracing entrepreneurship. He later became Vice President of Innovation at Creative Medtech Solutions (CMS), contributing to corporate development and product strategy. In collaboration with CMS’s founder, he co-founded UroMedTech, where he spearheaded the productization of a robot-guided fusion prostate biopsy system. While he remains a minority shareholder at UroMedTech, Keith has since founded Syndesi Capital, a firm dedicated to empowering early-stage Medtech, biotech, and deep-tech startups. Through Syndesi Capital, he provides strategic investment, fundraising expertise, and commercialization support, helping startups bridge the gap between innovation and market success. His extensive experience across R&amp;D, corporate strategy, and fundraising makes him a sought-after board director and advisor in the life sciences and healthcare sectors.</p>